The Recall Desk

Hazard

Appearance Specification recalls

2 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.

What the numbers show

Total
2
Critical
0
Severe
0
Most recent
2026-03-11

Of the 2 appearance specification recalls we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 0 (0%) are Severe.

About this hazard tag

Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all appearance specification recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.

A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.

1–2 of 2

  • LowFDA (Drugs)·D-0381-2026·2026-03-11

    Nilotinib capsules recalled after failing appearance tests at six months

    Cipla USA is recalling three lots of Nilotinib Capsules 150 mg after out-of-specification results in description and visual appearance testing at six-month long-term stability.

    Product
    NILOTINIB — NILOTINIB (NILOTINIB)
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-0382-2026·2026-03-11

    Nilotinib 200 mg capsules recalled after failing appearance tests

    Cipla USA is recalling one lot of Nilotinib Capsules 200 mg after out-of-specification results in description and visual appearance testing at six-month long-term stability.

    Product
    NILOTINIB — NILOTINIB (NILOTINIB)
    Category
    Drug
    Distribution
    Distributed nationwide